Publication | Closed Access

Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology

Alzheimer's DiseaseMedicineDementiaSalsolinol LevelParkinsonian PatientsCerebrospinal FluidNeuropharmacologyFrontotemporal DementiaNeurochemical BiomarkersNeurologyNeuroscienceClinical ChemistryLewy Body DementiaPharmacologyDrug Analysis